"Complex Oncology Center - Burgas" EOOD
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nikolov, Krasimir
PRESERVE 2, NCT04799249 / 2020-004930-39: Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

Recruiting
3
250
Europe, US, RoW
Trilaciclib, G1T28, COSELA, Placebo, 0.9% normal saline, 5 % Dextrose in water (D5W), Gemcitabine, Carboplatin
G1 Therapeutics, Inc., G1 Therapeutics, Inc.
TNBC - Triple-Negative Breast Cancer, Breast Cancer
06/24
10/24
Mihneva, Tonka
No trials found

Download Options